- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03668834
Comparing Recipient Site Preparation Using Dermabrasion, Dermaroller and Liquid Nitrogen Induced Blister in Non Cultured Epidermal Cell Suspension in Stable Vitiligo
A Comparative Study Between Recipient Site Preparation Using Dermabrasion,Liquid Nitrogen Induced Blister and Dermarolling System in Autologous Non Cultured Epidermal Cell Suspension Procedure in Stable Vitiligo Patients.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Chandigarh, India, 160012
- Recruiting
- PGIMER
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with a clinical diagnosis of generalized vitiligo
- Patients with symmetrical lesions of size > 1.5cm x 1cm present on trunk or extremities including acral areas.
- Vitiligo lesions has been stable for 1 year.
- Disease not responding to medical treatment, or there are residual patches (after medical therapy) of vitiligo .
- Maximum size of vitiligo patches to be selected for surgery will not be >100cm2.
Exclusion Criteria:
- Age less than 18 years
- Pregnancy and lactation
- Patient with actively spreading vitiligo
- History of Koebnerisation
- History of hypertrophic scars or keloidal tendency
- Bleeding disorders
- Patients with unrealistic expectation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Dermabrasion with NCES
Intervention-Dermabrasion with autologous non cultured epidermal cell suspension Recipient site preparation using dermabrasion followed by autologous non cultured epidermal cell suspension technique of 1 stable vitiligo patch of each of the 36 patients.
|
|
|
ACTIVE_COMPARATOR: Dermaroller with NCES
Intervention-Dermaroller with autologous non cultured epidermal cell suspension Recipient site preparation using dermaroller system followed by autologous non cultured epidermal cell suspension technique of 1 stable vitiligo patch of each of the 36 patients.
|
|
|
ACTIVE_COMPARATOR: Liquid nitrogen induced blister with NCES
Liquid nitrogen induced blister with autologous non cultured epidermal cell suspension Recipient site preparation using liquid nitrogen induced blister followed by autologous non cultured epidermal cell suspension technique of 1 stable vitiligo patch of each of the 36 patients.
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of extent of repigmentation in the vitiligo patches following dermabrasion, dermaroller system and liquid nitrogen induced blister followed by autologous non culured epidermal cell suspension.
Time Frame: 3 months from the surgery
|
The extent of repigmentation is done by measurement of lesions in a tracer paper before and after surgery and comparison of pre operative and post operative images clicked in Canon Powershot SX620HS 20.2MP camera and grading is done as ≤25% Minimal repigmentation 26-50% Mild repigmentation 51-75% Moderate repigmentation 76-90% Marked repigmentation >90% Excellent repigmentation |
3 months from the surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of colour match of repigmentation in the vitiligo patches following dermabrasion, dermaroller system and liquid nitrogen induced blister followed by autologous non culured epidermal cell suspension.
Time Frame: 3 months from the surgery
|
Comaprison is done by matching the colur of repigmented skin with the colour of normal skin and grading it as 'somewhat lighter than', 'same as' or 'somewhat darker than' normal skin.
|
3 months from the surgery
|
|
Comparison of pattern of repigmentation in the vitiligo patches following dermabrasion, dermaroller system and liquid nitrogen induced blister followed by autologous non cultured epidermal cell suspension.
Time Frame: 3 months from the surgery
|
Comparison is done by using pre operarative and post operative images of the lesions clicked using Canon SX620HS 20.2 MP camera and classified as
|
3 months from the surgery
|
|
Comparison of adverse events in the vitiligo patches following dermabrasion, dermaroller system and liquid nitrogen induced blister followed by autologous non cultured epidermal cell suspension.
Time Frame: 3 months from the surgery
|
Recipient site adverse effects
|
3 months from the surgery
|
|
Comparison of repigmentation in acral vs non acral areas in the vitiligo patches following dermabrasion, dermaroller system and liquid nitrogen induced blister followed by autologous non cultured epidermal cell suspension.
Time Frame: 3 months from the surgery
|
Repigmentation is compared between acral and non acral areas using pre operative and post operative images clicked by Canon SX620HS 20.2MP camera.
|
3 months from the surgery
|
|
Patient satisfaction index
Time Frame: 3 months from the surgery
|
Patients are asked to fill patient satisfaction index after surgery which is a questionaire with scores ranging from 0-30.
|
3 months from the surgery
|
|
Vitiligo quality of life index.
Time Frame: 3 months from the surgery
|
Comparison of vitiligo quality of life index before and after surgery in the vitiligo patches following dermabrasion, dermaroller system and liquid nitrogen induced blister followed by autologous non cultured epidermal cell suspension with scores ranging from 0-96.
|
3 months from the surgery
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- INT/TEC/2018/000424
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vitiligo
-
Hudson BiotechRecruitingNonSegmental Vitiligo | Nonsegmental Vitiligo (Stable)China
-
Kasr El Aini HospitalActive, not recruitingVitiligo VulgarisEgypt
-
Novartis PharmaceuticalsRecruitingNon-segmental VitiligoAustralia, United States, China, Japan, Canada
-
PfizerActive, not recruitingStable Nonsegmental Vitiligo | Active Nonsegmental VitiligoUnited States, Spain, China, Puerto Rico, Australia, Canada, Hungary, United Kingdom, Taiwan, Japan, Slovakia, Bulgaria, Germany, Belgium, Mexico, Italy, Poland, Turkey (Türkiye)
-
Centre Hospitalier Universitaire de NiceNot yet recruiting
-
PfizerCompletedStable Nonsegmental Vitiligo | Active Nonsegmental VitiligoUnited States, Spain, Australia, China, Germany, Canada, Japan, Italy, United Kingdom, South Africa, Mexico, Bulgaria, South Korea, Turkey (Türkiye), Poland
-
Sohag UniversityNot yet recruitingVitiligo - Macular Depigmentation
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingNon-segmental VitiligoChina
-
InventisBio Co., LtdNot yet recruitingVitiligo | Non-Segmental Vitiligo (NSV)China
-
Elixiron Immunotherapeutics (Hong Kong) Ltd.RecruitingNon-segmental VitiligoTaiwan, United States
Clinical Trials on Dermabrasion with NCES
-
Mohammed V Souissi UniversityUnknown
-
Massachusetts General HospitalMomelan TechnologiesTerminated
-
University of California, DavisCompleted
-
University of MinnesotaCompletedCicatrix | Dermabrasion | Coagulation, LaserUnited States
-
Centre Hospitalier Universitaire de NiceCompletedVitiligo - Macular DepigmentationFrance
-
Cairo UniversityNot yet recruiting
-
Milton S. Hershey Medical CenterNot yet recruitingScar Conditions and Fibrosis of Skin
-
Cairo UniversitySuspended
-
University of Wisconsin, MadisonRecruiting